Apollo Hospital Bhubaneswar Unveils Integrated Smart OR Solution by Biorad Medisys

The installation brings multiple endourology technologies into a single operating room setup, covering equipment for urinary stone management, prostate procedures, and endoscopic visualisation of the urinary tract.

Apollo Hospital, Bhubaneswar, has installed an integrated Smart Operating Room (OR) solution developed by Pune-based medical technology company Biorad Medisys.

The solution covers a range of laser treatment, tissue removal, and digital endoscopic technologies for complex urological procedures.

The installation brings together a comprehensive endourology portfolio, including Quantino TFL 75W, Tomi Morcellator, TOMI Resectoscope and TOMI Morcescope.

The Quantino TFL supports laser-based stone fragmentation and soft-tissue procedures. The TOMI Morcellator combines tissue removal with suction and fluid management capabilities, while the TOMI Resectoscope is designed for laser-based prostate enucleation. The accompanying Morcescope supports endoscopic tissue removal through a sheath with continuous irrigation.

The visualisation portfolio includes the CVS Elite (Indoscope Elite) system and 10 Indoscope Sleek flexible digital ureteroscopes for Retrograde Intrarenal Surgery (RIRS). The installation also features the Indoscope ACE Digital Semirigid Ureteroscope and Indoscope DPN Digital Semirigid Nephroscope to support endoscopic procedures.

The installation brings multiple endourology technologies into a single operating room setup, covering equipment for urinary stone management, prostate procedures, and endoscopic visualisation of the urinary tract.

Established in 2000 by Suchitra Hegde and Jitendra Hegde, Biorad Medisys develops and manufactures medical devices across orthopaedics, urology, and gastroenterology. Its portfolio includes orthopaedic implants for knee and hip replacement procedures, along with surgical disposables used across healthcare settings.

The company currently operates manufacturing facilities in Pune and Bengaluru. It also began operations at a new greenfield manufacturing facility dedicated to its Indovasive business in Bengaluru in March 2025, further strengthening its production capabilities.

Earlier, the Kotak-backed Pune-based Medtech company was reportedly in discussions to raise INR 400 Cr through a private funding round to accelerate its expansion plans while simultaneously laying the groundwork for a potential initial public offering (IPO) that could seek around INR 1,500 Cr.

Stay tuned for more such updates on Digital Health News